Topics
Pharmacology BU researcher Kusano will present at a symposium hosted by the Japan Association for Laboratory Animal Science
2025.10.17
Our researcher, Kaori Kusano from the Pharmacology Business Unit, will deliver an oral presentation at the Japan Association for Laboratory Animal Science, to be held from October 23 to 25, 2025, in Yonago city, Tottori prefecture, Japan.
If you plan to attend the conference, we encourage you to join the session and hear the presentation.
Conference Name: the Japan Association for Laboratory Animal Science
Date & Time: October 25 (Sat) 1:40 PM – 3:10 PM (JST)
Location: Yonago Convention Center BIGSHIP
Title: With the wishes of 990,000 people in my heart ~ My thoughts as a cancer researcher ~
Presentation number: Symposium 3
Presentation Summary
Cancer remains a disease with significant unmet medical needs, and research aimed at developing new treatments and drugs continues to advance every day. Within this field, animal experiments play a crucial role in cancer drug discovery. As laboratory animal researchers, enhancing our technical expertise and establishing robust pharmacological testing systems are essential missions that directly contribute to fulfilling patients’ hopes. I always keep in mind that our efforts ultimately lead to the recovery and smiles of many patients, and that our work carries the expectations of countless people.
In this symposium, I present an overview of cancer drug discovery research at Axcelead DDP. As both a laboratory animal researcher and a researcher involved in cancer drug discovery, I would also like to share my personal thoughts on how our continuous efforts can help bring hope to patients.
Axcelead DDP’s Soulution
Axcelead DDP has established in vitro and in vivo evaluation systems that accommodate a wide range of modalities, including small molecules, antibody therapeutics, nucleic acid drugs, RNA structure targets, and targeted protein degradation. In particular, we are dedicated to developing highly translatable assay systems, such as in vitro evaluations using fresh human cancer tissues, orthotopic transplantation models in which cancer cells are implanted into their organ of origin, and in vivo imaging systems utilizing X-ray CT equipment.
If you are facing challenges in drug discovery or are interested in any of our evaluation platforms, please feel free to reach out to us.
Kaori Kusano, Pharmacology Business Unit
Engaged in research and testing using laboratory animals such as mice and rats at multiple institutions, including RIKEN, Kirin Holdings Company, Limited, and Japan Charles River Co., Ltd.
Joined Axcelead Drug Discovery Partners, Inc. in 2018, where she is responsible for pharmacology studies, mainly in the field of oncology.
Certified Senior Laboratory Animal Technician and licensed Instructor for Laboratory Animal Technologists in Japan.